Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -46.69% is 69% below its 5-year average of -27.70%, near the low end of its 5-year range (-46.88%–-2.32%).
As of the fiscal period ended Tuesday, June 30, 2026. 17.78% below its 12-month average of -39.64%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -46.69%.
RETURN ON INVESTED CAPITAL (ROIC)
-46.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-39.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-38.86%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-27.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-23.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-22.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-17.78%
CURRENT VS 3Y AVG
-20.14%
CURRENT VS 5Y AVG
-68.57%
CURRENT VS 10Y AVG
-100.23%
CURRENT VS 15Y AVG
-103.22%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.29%
median of 484 covered companies
CURRENT VS SECTOR MEDIAN
-65.04%
vs the sector median at left
Cosmos Health Inc.
Market Cap
$18.82M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-39.64%
3Y Avg
-38.86%
5Y Avg
-27.70%
Market Cap
$18.77M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$20.93M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-2573.36%
3Y Avg
-1757.31%
5Y Avg
-1757.31%
Market Cap
$16.58M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$16.54M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$16.22M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
Market Cap
$15.91M
Return on Invested Capital (ROIC)
-41.81%
TTM Avg
-159.62%
3Y Avg
-298.97%
5Y Avg
-203.41%
Market Cap
$21.90M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$15.30M
Return on Invested Capital (ROIC)
-497.29%
TTM Avg
-141.17%
3Y Avg
-111.65%
5Y Avg
-80.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cosmos Health Inc. (COSM) | $18.82M | -46.69% | -39.64% | -38.86% | -27.70% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -171.06% | -106.73% | -106.73% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | -1489.99% | -2573.36% | -1757.31% | -1757.31% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -85.72% | -120.02% | -101.35% | -83.66% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -279.48% | -96.52% | -105.30% | -89.17% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -273.70% | -707.06% | -535.27% | -358.40% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -41.81% | -159.62% | -298.97% | -203.41% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -14.21% | -12.54% | -12.42% | -37.50% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -497.29% | -141.17% | -111.65% | -80.50% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.20M | -48.04% | -66.55% | -57.55% | -44.03% |
ROIC
-46.7%
ROE
-118.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -46.69% |
| 2026-03-31 | -45.97% |
| 2025-12-31 | -40.62% |
| 2025-09-30 | -31.24% |
| 2025-06-30 | -33.69% |
| 2025-03-31 | -35.74% |
| 2024-12-31 | -40.80% |
| 2024-09-30 | -42.95% |
| 2024-06-30 | -46.88% |
| 2024-03-31 | -45.02% |
| 2023-12-31 | -43.73% |
| 2023-09-30 | -28.07% |
| 2023-06-30 | -23.83% |
| 2023-03-31 | -18.86% |
| 2022-12-31 | -13.76% |
| 2022-09-30 | -2.32% |
| 2022-06-30 | -3.90% |
| 2022-03-31 | -7.51% |
| 2021-12-31 | -13.80% |
| 2021-09-30 | -10.85% |
| 2021-06-30 | -5.42% |
| 2021-03-31 | 2.78% |
| 2020-12-31 | 6.36% |
| 2020-09-30 | 9.32% |
| 2020-06-30 | 7.03% |
| 2020-03-31 | 0.90% |
| 2019-12-31 | -1.79% |
| 2019-09-30 | -13.37% |
| 2019-06-30 | -11.66% |
| 2019-03-31 | -9.02% |
| 2018-12-31 | -9.14% |
| 2018-09-30 | -13.64% |
| 2018-06-30 | -23.55% |
| 2018-03-31 | -32.71% |
| 2017-12-31 | -68.14% |
| 2017-09-30 | -39.10% |
| 2017-06-30 | -70.63% |
| 2017-03-31 | -163.38% |
| 2016-12-31 | -14.00% |
| 2016-09-30 | -47.38% |
| 2015-09-30 | -9.59% |
| 2015-06-30 | 81.53% |
| 2011-04-30 | -6222.39% |
| 2011-01-31 | -412466.41% |
